Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
The interim Phase I trial data was only from 35 people, but results look good so far.
This article was originally published at: https://arstechnica.com/health/2026/05/one-dose-of-gene-e...